Moreover, although CEBPB was not found to be modified by O-GlcNAc in Nic-treated breast cancer cells, we demonstrated that O-GlcNAcylation is required for the acquisition of the DNA-binding activity of CEBPB. This evidence concerns the gene CEBPB and breast cancer.